Research Topics
Species | DEEPAK CYRIL D'SOUZASummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot studyDEEPAK C D'SOUZA
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Neuropsychopharmacology 38:492-503. 2013....
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humansDEEPAK CYRIL D'SOUZA
Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 37:1632-46. 2012..Collectively, the findings suggest that CB1R systems modulate top-down and bottom-up processing...
Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophreniaDEEPAK CYRIL D'SOUZA
Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA
Biol Psychiatry 72:785-94. 2012..Accordingly, we examined the modulatory effects of brain nAChR systems on NMDAR antagonist-induced effects...
Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophreniaDEEPAK CYRIL D'SOUZA
Psychiatry Service, VA Connecticut Healthcare System, West Haven, USA
Am J Psychiatry 169:326-34. 2012..The purpose of this study was to measure β(2)*-nicotinic acetylcholine receptors in vivo and to relate levels to concurrent behavioral measures of smoking and schizophrenia...
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidenceDEEPAK CYRIL D'SOUZA
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Neuropsychopharmacology 37:1036-46. 2012..These findings provide preliminary support for further study of the antipsychotic potential of GlyT1 inhibitors...
Cannabis and psychosis/schizophrenia: human studiesDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, Psychiatry Service, VA Connecticut Healthcare System, 116A, 950 Campbell Avenue, West Haven, CT 06516, USA
Eur Arch Psychiatry Clin Neurosci 259:413-31. 2009..However, novel hypotheses including the role of cannabinoids on neurodevelopmental processes relevant to psychotic disorders are being studied...
Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humansDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Psychopharmacology (Berl) 202:569-78. 2009..Accordingly, we hypothesized that Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the principal active component of cannabis, would alter BDNF levels in humans...
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humansDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT, USA
Psychopharmacology (Berl) 198:587-603. 2008..This study evaluated whether pretreatment with a dopamine receptor antagonist altered the effects of Delta-9-THC in humans...
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabisDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 33:2505-16. 2008..These data suggest that frequent users of cannabis are either inherently blunted in their response to, and/or develop tolerance to the psychotomimetic, perceptual altering, amnestic, endocrine, and other effects of cannabinoids...
Enhanced sensitivity to the euphoric effects of alcohol in schizophreniaDEEPAK C D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 31:2767-75. 2006..The absence of 'beneficial' effects of alcohol does not support a self-medication hypothesis of alcohol use in schizophrenia...
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosisDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 29:1558-72. 2004..These data warrant further study of whether brain cannabinoid receptor function contributes to the pathophysiology of psychotic disorders...
gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociationDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, West Haven Veterans Affairs Medical Center, West Haven, Connecticut, USA
Biol Psychiatry 59:128-37. 2006....
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addictionDEEPAK CYRIL D'SOUZA
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Biol Psychiatry 57:594-608. 2005..Recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and psychotic disorders...
The effects of cannabinoids on serum cortisol and prolactin in humansMohini Ranganathan
Schizophrenia Biological Research Center, VA Connecticut Healthcare System, West Haven, CT, USA
Psychopharmacology (Berl) 203:737-44. 2009..Furthermore, relative to controls, frequent users of cannabis were hypothesized to show altered baseline levels of these hormones and blunted Delta-9-THC-induced changes of these hormones...
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case historiesMichelle Carbuto
Psychiatry Service, VA Connecticut Healthcare System, 116A, VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, USA
Psychopharmacology (Berl) 219:885-96. 2012..Despite increasing interest in the cannabinoid receptor system, use of intravenous THC as a research tool has been limited by concerns about its abuse liability and psychoactive effects...
Cannabinoids and psychosisR Andrew Sewell
Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Int Rev Psychiatry 21:152-62. 2009..Further work is necessary to identify the factors that underlie individual vulnerability to cannabinoid-related psychosis and to elucidate the biological mechanisms underlying this risk...
Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholismJohn H Krystal
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Neuropsychopharmacology 31:1793-800. 2006..However, these data suggest that at levels of NMDA receptor antagonism associated with heavy drinking, this protective effect of naltrexone on drinking is no longer present...
Probing GABA receptor function in schizophrenia with iomazenilKyungheup Ahn
Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 36:677-83. 2011..The greater vulnerability of schizophrenia patients to the effects of iomazenil relative to controls provides further support for the GABA-deficit hypothesis of schizophrenia...
[Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia]R Andrew Sewell
Servico de Psiquiatria, VA Connecticut Healthcare System, West Haven, CT 06516, EUA
Rev Bras Psiquiatr 32:S15-30. 2010..Finally, further work is necessary to identify the factors that underlie individual vulnerability to cannabinoid-related psychosis and to elucidate the biological mechanisms underlying this risk...
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humansMohini Ranganathan
Psychiatry Service, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA
Biol Psychiatry 72:871-9. 2012..However, there is little experimental data on the effects of SA in humans...
Cannabinoids and psychosisDEEPAK CYRIL D'SOUZA
Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Int Rev Neurobiol 78:289-326. 2007....
Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smokingJulie K Staley
Yale University School of Medicine, 950 Campbell Avenue, New Haven, CT 06516, USA
Arch Gen Psychiatry 62:877-88. 2005..Adaptations in gamma-aminobutyric acid type A (GABA(A))-benzodiazepine receptors contribute to the neurobiology of human alcohol dependence and withdrawal...
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjectsJohn H Krystal
Schizophrenia Biological Research Center 116 A, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Psychopharmacology (Berl) 179:303-9. 2005..Some of the behavioral consequences of deficits in N-methyl-D-aspartate (NMDA) glutamate receptor function are thought to arise from the disinhibition of cortical glutamatergic circuitry...
GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depressionIrina Esterlis
Department of Psychiatry, Yale University School of Medicine, Veteran s Affairs Connecticut Healthcare System VACHS, 116A6 West Haven, Connecticut 06516, USA
Synapse 63:1089-99. 2009..Aberrant regulation of GABA(A)-BZR function in vulnerable smokers may explain why some smokers experience subsyndromal anxiety and depression...
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smokingKelly P Cosgrove
Department of Psychiatry, Yale University School of Medicine, 950 Campbell Ave, Mail Code 116A6, West Haven, CT 06516, USA
Arch Gen Psychiatry 66:666-76. 2009..Variations in beta(2)*-nAChR availability during the course of abstinence may be related to the urge to smoke, the extent of nicotine withdrawal, and successful abstinence...
Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokersJulie K Staley
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA
J Neurosci 26:8707-14. 2006..Greater beta2*-nAChR availability during early abstinence may impact the ability of smokers to maintain abstinence...
Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptorsLouis Trevisan
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
Alcohol Clin Exp Res 32:36-42. 2008....
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phaseKelly P Cosgrove
Yale University School of Medicine, New Haven, Connecticut, USA
J Nucl Med 48:1633-40. 2007..We examined the availability of nAChR containing the beta(2) subunit in healthy men and women and the influence of menstrual phase among women...
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication developmentJohn H Krystal
Schizophrenia Biological Research Center 116 A, VA Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA
Psychopharmacology (Berl) 169:215-33. 2003..The purpose of this review is to consider the possibility that agents that attenuate these two components of NMDA receptor antagonist response may play complementary roles in the treatment of schizophrenia...
Revisiting cycloid psychosis: a case of an acute, transient and recurring psychotic disorderVinod H Srihari
Department of Psychiatry, Yale University School of Medicine, CMHC, 34 Park Street, New Haven, CT 06508, USA
Schizophr Res 82:261-4. 2006..While this disorder, of unknown incidence, is not well reported in the U.S., it is worthy of further investigation and clinical attention given its generally favorable prognosis and potentially distinct pathophysiology and treatment...
Research Grants
- NEUROBIOLOGY OF CANNABIS BEHAVIORAL EFFECTSDEEPAK D SOUZA; Fiscal Year: 2003..Secondary measures include measures of drug liking, movement rating scales and long term follow-up assessment of cannabis use. ..
- NEUROBIOLOGY OF CANNABIS EFFECTSDEEPAK D SOUZA; Fiscal Year: 2009....
- Imaging Nicotinic Acetylcholine Receptors in SchizophreniaDEEPAK D SOUZA; Fiscal Year: 2009..This grant application proposes to use brain imaging to study the nicotine receptor system in schizophrenia. ..
- Cannabinoids, Neural Synchrony and Information ProcessingDEEPAK D SOUZA; Fiscal Year: 2007....
- Cannabinoid Receptor Function in Alcoholism: Effects of D-9-THCDEEPAK D SOUZA; Fiscal Year: 2007..These results may reflect indirect evidence of altered CB-1R function in FHP individuals. ..
- NEUROBIOLOGY OF CANNABIS EFFECTSDEEPAK D SOUZA; Fiscal Year: 2007....
- GLYCINE-KETAMINE INTERACTIONS IN HEALTHY SUBJECTSDEEPAK D SOUZA; Fiscal Year: 2002..Pilot data (n=12) towards this proposal suggests that glycine reduces ketamine-induced perceptual alterations, negative symptoms and impairments on recall without worsening positive symptoms. ..
- Imaging Nicotinic Acetylcholine Receptors in SchizophreniaDEEPAK CYRIL contact D apos SOUZA; Fiscal Year: 2010..This grant application proposes to use brain imaging to study the nicotine receptor system in schizophrenia. ..
